Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells
Cancer Cell · 2024-09 · 42 (9) · 1582-1597.e10
DOI: 10.1016/j.ccell.2024.08.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024-09. Verfasst von Kevin Wang und 37 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Programmed Cell Death 1 Receptor, Melanoma, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Damon Runyon Cancer Research Foundation, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Immunai Inc, New York, NY 10016, USA.
- Department of Medicine, Grossman School of Medicine, New York University, New York, NY 10016, USA.
- Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.
- Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Förderung
- NCI NIH HHS
- Damon Runyon Cancer Research Foundation
- National Institutes of Health
- Institute for Translational Medicine and Therapeutics
- Bristol-Myers Squibb
- Perelman School of Medicine, University of Pennsylvania
- Merck
- Parker Institute for Cancer Immunotherapy
Zitieren
APA
Wang, K., Coutifaris, P., Brocks, D., Wang, G., Azar, T., Solis, S., Nandi, A., Anderson, S., Han, N., Manne, S., Kiner, E., Sachar, C., Lucas, M., George, S., Yan, P. K., Kier, M. W., Laughlin, A. I., Kothari, S., Giles, J., …, & Huang, A. C. (2024). Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells. Cancer Cell, 42(9), 1582-1597.e10. https://doi.org/10.1016/j.ccell.2024.08.007
Vancouver
Wang K, Coutifaris P, Brocks D, Wang G, Azar T, Solis S, et al. Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells. Cancer Cell. 2024;42(9):1582-1597.e10. doi:10.1016/j.ccell.2024.08.007
BibTeX
@article{Wang2024,
author = {Wang, Kevin and Coutifaris, Paulina and Brocks, David and Wang, Guanning and Azar, Tarek and Solis, Sabrina and Nandi, Ajeya and Anderson, Shaneaka and Han, Nicholas and Manne, Sasikanth and Kiner, Evgeny and Sachar, Chirag and Lucas, Minke and George, Sangeeth and Yan, Patrick K and Kier, Melanie W and Laughlin, Amy I and Kothari, Shawn and Giles, Josephine and Mathew, Divij and Ghinnagow, Reem and Alanio, Cecile and Flowers, Ahron and Xu, Wei and Tenney, Daniel J and Xu, Xiaowei and Amaravadi, Ravi K and Karakousis, Giorgos C and Schuchter, Lynn M and Buggert, Marcus and Oldridge, Derek and Minn, Andy J and Blank, Christian and Weber, Jeffrey S and Mitchell, Tara C and Farwell, Michael D and Herati, Ramin S and Huang, Alexander C},
title = {Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells},
journal = {Cancer Cell},
year = {2024},
volume = {42},
number = {9},
pages = {1582--1597.e10},
doi = {10.1016/j.ccell.2024.08.007}
}
EUVIMED